Fonte: Alzheimer's & dementia. Unidade: FM
Assuntos: DOENÇA DE ALZHEIMER (DIAGNÓSTICO;LÍQUIDO CÉFALO-RAQUIDIANO), BIOMARCADORES, DOENÇAS NEURODEGENERATIVAS (LÍQUIDO CÉFALO-RAQUIDIANO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTSSON, Niklas et al. The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer's & dementia, v. 7, n. 4, p. 386-395, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.jalz.2011.05.2243. Acesso em: 10 maio 2024.APA
Mattsson, N., Andreasson, U., Persson, S. S., Arai, H., Batish, S. D., Bernardini, S., et al. (2011). The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers. Alzheimer's & dementia, 7( 4), 386-395. doi:10.1016/j.jalz.2011.05.2243NLM
Mattsson N, Andreasson U, Persson SS, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, Fagan AM, Forlenza O, Frisoni GB, Galask D, Galimberti D, Hampel H, Handberg A, Heneka MT, Herskovits AZ, Herukka S-K, Holtzman DM, Humpel C, Hyman BT, Iqbal K, Jucker M, Kaeser SA, Kaiser E, Kapaki E, Kidd D, Klivenyi P, Knudsen CS, Kummer MP, Lui J, Llado A, Lewczuk P, Li Q-X, Martins R, Masters C, McAuliffe J, Mercken M, Moghekar A, Molinuevo JL, Montine TJ, Nowatzke W, O’Brien R, Otto M, Paraskevas GP, Parnetti L, Petersen RC, Prvulovic D, Reus HPM de, Rissman RA, Scarpini E, Stefani A, Soinine H, Schroder J, Shaw LM, Skinningsrud A, Skrogstad B, Spreer A, Talib L, Teunissen C, Trojanowski JQ, Tumani H, Umek RM, Broeck BV, Vanderstichele H, Vecsei L, Verbeek MM, Windisch M, Zhang J, Zetterberg H, Blennow K. The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers [Internet]. Alzheimer's & dementia. 2011 ;7( 4): 386-395.[citado 2024 maio 10 ] Available from: https://doi.org/10.1016/j.jalz.2011.05.2243Vancouver
Mattsson N, Andreasson U, Persson SS, Arai H, Batish SD, Bernardini S, Bocchio-Chiavetto L, Blankenstein MA, Carrillo MC, Chalbot S, Coart E, Chiasserini D, Cutler N, Dahlfors G, Duller S, Fagan AM, Forlenza O, Frisoni GB, Galask D, Galimberti D, Hampel H, Handberg A, Heneka MT, Herskovits AZ, Herukka S-K, Holtzman DM, Humpel C, Hyman BT, Iqbal K, Jucker M, Kaeser SA, Kaiser E, Kapaki E, Kidd D, Klivenyi P, Knudsen CS, Kummer MP, Lui J, Llado A, Lewczuk P, Li Q-X, Martins R, Masters C, McAuliffe J, Mercken M, Moghekar A, Molinuevo JL, Montine TJ, Nowatzke W, O’Brien R, Otto M, Paraskevas GP, Parnetti L, Petersen RC, Prvulovic D, Reus HPM de, Rissman RA, Scarpini E, Stefani A, Soinine H, Schroder J, Shaw LM, Skinningsrud A, Skrogstad B, Spreer A, Talib L, Teunissen C, Trojanowski JQ, Tumani H, Umek RM, Broeck BV, Vanderstichele H, Vecsei L, Verbeek MM, Windisch M, Zhang J, Zetterberg H, Blennow K. The Alzheimer’s Association external quality control program for cerebrospinal fluid biomarkers [Internet]. Alzheimer's & dementia. 2011 ;7( 4): 386-395.[citado 2024 maio 10 ] Available from: https://doi.org/10.1016/j.jalz.2011.05.2243
